Control of Leukocyte Function
NCT03027232 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-04-27
Summary
The protocol is to draw peripheral blood from healthy volunteers for in vitro studies. The aims of these in vitro studies are to determine the cellular and intracellular mechanisms by which hypertonic saline and ATP release regulate neutrophil and lymphocyte functions.
Conditions
- Inflammation, Brain
Interventions
- OTHER
-
No intervention (drugs) will be given. Purpose: collecting blood for in vitro studies
No drugs or interventions are given. Single purpose is to draw blood from healthy subjects to study immune cell biology in vitro. No records about subjects to be kept.
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2017-12-15
- Completion
- 2017-12-15
Countries
- United States
Study Locations
More Related Trials
-
Manufacture of Clinical T-cell Products for Future Treatment
NCT05713513 ·Status: COMPLETED
-
Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
NCT00001349 ·Status: TERMINATED
-
Clinical Investigational Protocol for 2 RBC Single Unit Recovery on MCS®+ 8150 Using LN832 Disposable Sets (US)
NCT01764061 ·Status: COMPLETED
-
Evaluation of a Device That Separates Blood Cells From Serum/Plasma
NCT02853448 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals.
NCT05852249 ·Status: UNKNOWN
-
Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial
NCT03301779 ·Status: COMPLETED ·Phase: PHASE2
-
Acquiring Convalescent Specimens for COVID-19 Antibodies
NCT04342195 ·Status: COMPLETED
-
A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host-Microbe Scientific Study
NCT00764023 ·Status: COMPLETED
-
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
NCT05669261 ·Status: UNKNOWN ·Phase: PHASE1
-
Controls and Healthy Vasculature Initiative
NCT05403151 ·Status: RECRUITING
-
A Study of Sterile Saline Infusion in Healthy Volunteers
NCT06194578 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
NCT00067054 ·Status: RECRUITING
-
In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution
NCT02298842 ·Status: COMPLETED ·Phase: NA
-
Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells
NCT04418934 ·Status: WITHDRAWN ·Phase: PHASE2
-
Blood Collection for Use in Serological Assay Development From Healthy Adult Volunteers
NCT00500032 ·Status: COMPLETED ·Phase: NA
-
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1
NCT07015437 ·Status: RECRUITING ·Phase: PHASE2
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
NCT04376034 ·Status: RECRUITING ·Phase: PHASE3
-
DxH520 Pediatric Reference Interval Verification
NCT03243266 ·Status: COMPLETED
-
Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick
NCT00339911 ·Status: ENROLLING_BY_INVITATION
-
Blood Collection for COM/BSBS
NCT06082661 ·Status: RECRUITING
-
Procalcitonin Test Reference Range Determination
NCT02591121 ·Status: COMPLETED
-
An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System
NCT05239455 ·Status: COMPLETED ·Phase: NA
-
Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay
NCT01750203 ·Status: COMPLETED
-
Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting
NCT02176239 ·Status: COMPLETED
-
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
NCT04456413 ·Status: TERMINATED ·Phase: PHASE2